Value Bridge — S.E. REGL MEDICAL CENTER
Current $-15M → Target $-8M (+$6.6M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-14.9M
Current EBITDA
$-8.3M
Target EBITDA
+$6.6M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$1.5M
Payer Mix Optimization
$3.6M
Cost to Collect Reduction
$1.2M
Clean Claim Improvement
$0.9M
Volume & Rate Growth
$6.0M
What This Means
The 7-lever model projects a 0% EBITDA uplift from $-15M to $-8M. The highest-impact lever is Volume & Rate Growth at $2.4M probability-weighted.
IC talking point: "We see $7M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $72M in equity value creation."